A novel, personalized treatment program with the ability to reverse the cognitive impairment caused by Alzheimer's disease may have been discovered by a researcher from the Buck Institute Research on Aging, in Novato, California and the University of California-Los Angeles. The findings of the study, which focused on combined therapies rather than finding a cure for the disease alone, were published at the Aging journal.
During his research, Dale E. Bredesen created a personalized treatment program that he believes is able to reverse the process of development of the disease in patients with memory loss.
"In the past decade alone, hundreds of clinical trials have been conducted for Alzheimer's at an aggregate cost of over a billion dollars, without success," Bredesen noted, explaining that combined therapies have better results in chronic diseases like cancer, cardiovascular diseases or HIV, but that the personalized treatment approach has not been studied in the case of Alzheimer's. However, the disease has been proven to be caused by molecular interactions, siliar to other diseases where the personalized treatment approach has worked. "That suggested that a broader-based therapeutics approach, rather than a single drug that aims at a single targ